Clovis Oncology
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-6.63-20.44-11.85-3.57-4.89-9.23-2.54-1.40-1.09-1.24-0.04-4.89
Price/Sales ratio
N/AN/A139.28N/A21.91K57.639.803.922.452.200.1157.63
Price/Book Value ratio
3.673.475.724.19-470.338.706.38-3.22-2.54-1.17-0.02-470.33
Price/Cash Flow ratio
-7.50-24.09-16.21-4.98-6.40-12.26-2.55-1.73-1.60-1.67-0.06-6.40
Price/Free Cash Flow ratio
-7.38-24.05-15.90-4.92-6.39-12.07-2.17-1.63-1.54-1.67-0.06-6.39
Price/Earnings Growth ratio
-0.08-30.35-0.19-0.030.660.480.64-0.270.020.02-0.000.48
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A-1063.00%N/A10.25%78.85%76.85%75.74%74.89%73.89%65.19%10.25%
Operating Profit Margin
N/AN/A-1163.00%N/A-477862.82%-428.07%-349.95%-263.44%-183.67%-156.80%-225.56%-477862.82%
Pretax Profit Margin
N/AN/A-1157.60%N/A-488680.76%-630.46%-385.16%-278.74%-224.74%-178.09%-246.49%-488680.76%
Net Profit Margin
N/AN/A-1174.53%N/A-447611.53%-624.01%-385.80%-280.00%-224.41%-177.82%-246.10%-447611.53%
Effective Tax Rate
0.03%-0.06%-1.46%7.61%8.40%1.02%-0.16%-0.45%0.14%0.15%0.16%1.02%
Return on Assets
-50.67%-13.01%-20.35%-49.46%-95.77%-47.11%-42.61%-59.80%-60.97%-55.94%-72.64%-95.77%
Return On Equity
-55.41%-16.97%-48.25%-117.36%9607.51%-94.22%-251.25%229.78%232.57%94.86%73.67%-94.22%
Return on Capital Employed
-55.12%-13.32%-21.45%-59.06%-124.67%-36.35%-45.24%-70.22%-71.84%-67.10%57.56%-124.67%
Liquidity Ratios
Current Ratio
11.9115.6810.287.144.257.694.552.751.68N/A0.137.69
Quick Ratio
11.8515.6110.287.144.257.354.332.551.511.470.107.35
Cash ratio
11.8515.4210.103.683.295.691.761.211.291.140.075.69
Days of Sales Outstanding
N/AN/AN/AN/A566.2140.6449.3152.4858.8165.9269.3669.36
Days of Inventory outstanding
N/AN/AN/AN/AN/A855.45447.64279.05271.41128.67117.00855.45
Operating Cycle
N/AN/AN/AN/A566.21896.09496.96331.54330.22194.60134.10896.09
Days of Payables Outstanding
N/AN/A6.7110.9056.89K471.04471.53339.22235.86256.72185.69471.04
Cash Conversion Cycle
N/AN/A-6.71N/A-56.33K425.0425.42-7.6894.35-62.11-87.47-56.33K
Debt Ratios
Debt Ratio
0.080.230.360.390.770.380.661.010.881.332.200.77
Debt Equity Ratio
0.090.300.860.93-77.350.763.92-3.90-3.37-2.25-1.82-77.35
Long-term Debt to Capitalization
N/AN/A0.460.481.010.430.791.341.421.8012.221.01
Total Debt to Capitalization
N/AN/A0.460.481.010.430.791.341.421.7911.271.01
Interest Coverage Ratio
N/AN/A-55.88-35.80-34.37-22.78-25.32-22.19-12.86N/A-6.50-34.37
Cash Flow to Debt Ratio
N/AN/A-0.40-0.90-0.94-0.92-0.63-0.47-0.47-0.31-0.38-0.94
Company Equity Multiplier
1.091.302.372.37-100.311.995.89-3.84-3.81-1.69-0.82-100.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-8.59N/A-3.41K-4.70-3.83-2.26-1.53-1.31-1.71-3.41K
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.011.011.001.011.171.051.031.001.001.01
Cash Flow Coverage Ratio
N/AN/A-0.40-0.90-0.94-0.92-0.63-0.47-0.47-0.31-0.38-0.94
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A-59.87-47.41-57.42-50.83N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A